Early Phase II Trials for Cocaine Medication Development - 1
Completed
National Institute on Drug Abuse (NIDA)
Phase 2
1996-08-01
The purpose of this study is to develop models for early Phase II testing of potential
medications for cocaine dependence: amoxapine, risperidone and other agents.
The study was a controlled pilot trial of risperidone in opiate-dependent patients on
methadone maintenance. The study explored whether risperidone reduced cocaine use, cocaine
craving, and cocaine subjective effects in patients on methadone maintenance who abused
cocaine and whether it had an acceptable side effect profile. This
Early Phase II Trials for Cocaine Medication Development - 1
Completed
New York State Psychiatric Institute
Phase 2
1996-08-01
The purpose of this study is to develop models for early Phase II testing of potential
medications for cocaine dependence: amoxapine, risperidone and other agents.
The study was a controlled pilot trial of risperidone in opiate-dependent patients on
methadone maintenance. The study explored whether risperidone reduced cocaine use, cocaine
craving, and cocaine subjective effects in patients on methadone maintenance who abused
cocaine and whether it had an acceptable side effect profile. This
Early Phase II Trials for Cocaine Medication Development - 1
Completed
Research Foundation for Mental Hygiene, Inc.
Phase 2
1996-08-01
The purpose of this study is to develop models for early Phase II testing of potential
medications for cocaine dependence: amoxapine, risperidone and other agents.
The study was a controlled pilot trial of risperidone in opiate-dependent patients on
methadone maintenance. The study explored whether risperidone reduced cocaine use, cocaine
craving, and cocaine subjective effects in patients on methadone maintenance who abused
cocaine and whether it had an acceptable side effect profile. This
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.
Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data.
The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free.
thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user.
Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
Alerts Available With Subscription
Alerts are available for users with active subscriptions.
